(Q31804341)

3 July 2017

title

Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality (English)

1 reference

3 July 2017

0 references

P Kerokoski

1

1 reference

3 July 2017

H Soininen

series ordinal

2

1 reference

3 July 2017

T Pirttilä

series ordinal

3

1 reference

3 July 2017

publication date

1 February 2001

1 reference

Neurochemistry International

3 July 2017

published in

1 reference

3 July 2017

volume

38

1 reference

3 July 2017

issue

2

1 reference

3 July 2017

page(s)

127-134

1 reference

Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes.

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Expression of beta-amyloid precursor and Bcl-2 proto-oncogene proteins in rat retinas after intravitreal injection of aminoadipic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

General and dramatic glial reaction in Alzheimer brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Glial fibrillary acidic protein and Alzheimer-type senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Comparison of the effects of hydrogen peroxide, 4-hydroxy-2-nonenal and beta-amyloid (25-35) upon calcium signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

beta-Amyloid peptide-induced morphological changes coincide with increased K+ and Cl- channel activity in rat cortical astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Nanomolar amyloid beta protein-induced inhibition of cellular redox activity in cultured astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of beta-amyloid (1-40).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

beta-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

beta-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900071-1

7 January 2021

10.1016/S0197-0186(00)00071-1

Identifiers

DOI

1 reference

3 July 2017

1 reference